Interview with Marco Caligiuri, Country Manager, Celgene Turkey
What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is always challenging…
Address: Celgene Türkiye
Büyükdere Cad. N:103
Şarlı İş Merkezi B Blok Daire:3
34394 Mecidiyeköy, İstanbul,Turkey
Tel: +90 212 354 1806
Web: http://www.celgene.com.tr/
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer.
Celgene Turkey operates in Turkey since March 2008.
What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is always challenging…
Gamze Çıtıroğlu, Murat Çıtıroğlu and Pınar Çakır of Ekin Kimya discuss the progress of the Turkish pharma industry moving towards biotechnology. Moreover, they give insights into Ekin Kimya’s partnership strategy…
Funda Gücer, country manager at Mylan Turkey, portrays her experience in introducing the company to the Turkish market. She provides her expert insights into current trends in the Turkish generics…
Uğur Bingöl, general manager of Ibrahim Etem Menarini, speaks of his company’s rapid growth and new product lines. He also describes his take on the Turkish pharmaceutical market and outlines…
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares the company’s plans to become Turkey’s leading biotech entity and gives insights into the group’s international expansion plans. He…
The Minister of Health of the Republic of Turkey, Dr Fahrettin Koca, provides an overview of the current state of the Turkish healthcare ecosystem, highlighting its opportunities and challenges. He…
Handan Boyce, general manager of the Istanbul Lütfi Kırdar International Convention and Exhibition Center, offers her insights into the Turkish congress sector, underlining the industry’s strong suits and highlighting the…
Levent Canyurt, CEO and founder of BIEM Ilac, shares how he transformed the company from a domestic pharmaceutical distributor into an international player, with an innovative portfolio for the treatment…
Mehmet Baharoglu and Beril Tezcanli of Birgi Mefar Group, Turkey’s leading CMO with a proven track record and experience of production across all small and medium volume injectable dosage forms…
* Dr Fabrizio Guidi has left his role as country chair & general manager Rx of Sanofi Turkey and is currently Sanofi’s general manager of diabetics and cardiovascular for Germany, Switzerland…
Barış Özyurtlu, general manager of Berko Pharmaceuticals, one of the fastest growing companies in Turkey, provides insights into the company’s innovative vision and proprietary technologies, such as its spoon-shaped product…
Şekib Avdagiç, president of the Istanbul Chamber of Commerce and Istanbul Convention and Visitors Bureau (ICVB) provides an in-depth analysis of the ICVB’s services, the main trends shaping the city’s…
Mahmut Oguzcan, country business leader of 3M Turkey, offers his expert insights into the Turkish medical devices market. He explains how Turkey’s Health Transformation Program (HTP) and private-public partnership (PPP)…
See our Cookie Privacy Policy Here
